
|Articles|February 1, 2004
- LCGC Europe-02-01-2004
- Volume 17
- Issue 2
Quo Vadis 21 CFR 11
Author(s)R.D. McDowall
In the welcome return of this column, Bob McDowall revisits the evolving topic of 21 CFR 11 compliance, as it applies to chromatographers. He examines the FDA's activities in 2003 and outlines the current status of its regulations over, and guidance for, electronic records issues.
Advertisement
Articles in this issue
almost 22 years ago
Comprehensive Two-Dimensional Gas Chromatographyalmost 22 years ago
Tissue Sample Preparation — Not the Same Old Grindalmost 22 years ago
Broad Peaksalmost 22 years ago
Analysis of Combinatorial Natural Products by HPLC and CENewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5




